Potassium Carbonate → HCID 18349617, Verbindung

HRID 1956850Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1956850
Br[CH2:2][C:3]([O:5][CH3:6])=[O:4].[Cl:7][C:8]1[CH:25]=[CH:24][C:11]([O:12][CH2:13][CH2:14][NH:15][CH2:16][CH2:17][CH2:18][N:19]2[CH:23]=[CH:22][N:21]=[CH:20]2)=[CH:10][CH:9]=1.C(=O)([O-])[O-].[K+].[K+]>CC(C)=O.CCOCC>[Cl:7][C:8]1[CH:9]=[CH:10][C:11]([O:12][CH2:13][CH2:14][N:15]([CH2:16][CH2:17][CH2:18][N:19]2[CH:23]=[CH:22][N:21]=[CH:20]2)[CH2:2][C:3]([O:5][CH3:6])=[O:4])=[CH:24][CH:25]=1

Komponenten

6

Versuchsvorschrift

Methyl bromoacetate (2.1 g) was added to a stirred mixture of N-[2-(4-chlorophenoxy)ethyl]-3-(imidazol-1-yl)propylamine (3.87 g) and anhydrous potassium carbonate (5.73 g) in dry acetone (180 ml). The mixture was stirred and boiled under reflux for 7 hours, then left to stand at ambient temperature for 18 hours then hot filtered. The filtrate was evaporated to dryness and the residue was purified by chromatography on silica using ethyl acetate/triethylamine, 9 to 1 as the mobile phase. The product was obtained as an oil which was dissolved in ether, and extracted into 5M hydrochloric acid. The acid extracts were basified with 5M sodium hydroxide solution and the product extracted into ether to give methyl N-[2-(4-chlorophenoxy)ethyl]-N-[3-(imidazol-1-yl)propyl]glycinate as an oil.

Aufarbeitung

  1. temperatureunder reflux for 7 hours
  2. waitleft
  3. customThe filtrate was evaporated to dryness
  4. customthe residue was purified by chromatography on silica
  5. customThe product was obtained as an oil which
  6. extractionextracted into 5M hydrochloric acid
  7. extractionthe product extracted into ether

Quellen und Nachweise

ORD-Eintrag
ord-b74653787e5a45cab88a53a6a5af6672
Quelldatensatz
uspto-grants-1998_07
Patentnummer
US05780642

Notizen zur Reaktion

Wird geladen…